Device Trial Radar · NCT06511167
Post-market Surveillance Study to Evaluate the Quality of Life and the Safety and Effectiveness of the TIGR® Matrix After Reconstructive Breast Surgery
Last checked: Nov 20, 2026Latest source record: May 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
135
Planned (sponsor's estimate)
Start
Nov 8, 2024
Primary completion
Jan 2029
Study completion Jan 2029
Sponsor
- Lead sponsor
- AWOgynAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Esculape GmbH
- First posted
- Jul 19, 2024
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this observational study is to evaluate the quality of life of participants who have undergone implant-based breast surgery. This will be done using the BREAST-Q questionnaire. The study also aims to demonstrate that the fully resorbable TIGR® Matrix is safe and effective.
Conditions
- Implant Based Breast Reconstruction
Interventions
TIGR® MatrixDevice
bioresorbable, synthetic, surgical mesh
Primary outcomes
What the sponsor says the trial is designed to measure.
- Quality of Life 12 months after surgery (BREAST-Q)Time frame: 12 months after surgery
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Krankenhaus St. Elisabeth und St. Barbara Halle (Saale) GmbH
Halle, Germany · Recruiting
GRN-Klinik Weinheim
Weinheim, Baden-Wurttemberg, Germany · Active not recruiting
Klinik und Poliklinik für Frauenheilkunde Technische Universität München
München, Bavaria, Germany · Recruiting
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.